Deccan Health Care Ltd

₹ 12.5 -1.03%

05 Jun - close price

About

Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products^[1]

Key Points

Business Overview:^[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com

Website BSE

Market Cap ₹ 30.9 Cr.
Current Price ₹ 12.5
High / Low ₹ 23.0 / 6.65
Stock P/E 13.5
Book Value ₹ 44.5
Dividend Yield 0.00 %
ROCE 3.09 %
ROE 2.11 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 0.28 times its book value

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 19.5%
Company has a low return on equity of 1.67% over last 3 years.
Contingent liabilities of Rs.16.8 Cr.
Debtor days have increased from 72.9 to 97.1 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	15.86	11.22	17.19	15.34	15.97	15.06	18.82	20.43	20.82	21.47	24.40	23.03	20.26
	15.07	10.40	16.16	14.10	15.31	14.19	17.70	19.83	20.19	20.75	22.69	21.35	19.49
Operating Profit	0.79	0.82	1.03	1.24	0.66	0.87	1.12	0.60	0.63	0.72	1.71	1.68	0.77
OPM %	4.98%	7.31%	5.99%	8.08%	4.13%	5.78%	5.95%	2.94%	3.03%	3.35%	7.01%	7.29%	3.80%
	0.01	0.01	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00
Interest	0.03	0.02	0.00	0.02	0.02	0.02	0.03	0.02	0.02	0.02	0.16	0.04	0.14
Depreciation	0.36	0.39	0.32	0.40	0.36	0.36	0.37	0.37	0.36	0.41	0.33	0.35	0.38
Profit before tax	0.41	0.42	0.71	0.82	0.29	0.49	0.72	0.21	0.25	0.30	1.22	1.29	0.25
Tax %	26.83%	26.19%	25.35%	32.93%	58.62%	26.53%	25.00%	23.81%	44.00%	30.00%	26.23%	26.36%	8.00%
	0.31	0.31	0.53	0.55	0.13	0.37	0.54	0.16	0.14	0.21	0.90	0.95	0.23
EPS in Rs	0.18	0.18	0.31	0.27	0.06	0.18	0.26	0.07	0.06	0.08	0.36	0.38	0.09
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2010	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	39.52	16.16	29.34	37.83	44.25	42.24	33.78	33.17	45.02	59.73	75.13	89.17
	38.54	9.81	16.54	23.77	27.44	30.57	31.74	27.54	42.97	55.97	71.95	84.29
Operating Profit	0.98	6.35	12.80	14.06	16.81	11.67	2.04	5.63	2.05	3.76	3.18	4.88
OPM %	2.48%	39.29%	43.63%	37.17%	37.99%	27.63%	6.04%	16.97%	4.55%	6.29%	4.23%	5.47%
	0.09	-0.17	0.05	2.07	0.08	0.06	0.06	-3.46	0.02	0.01	0.01	0.01
Interest	0.10	1.48	2.14	1.50	1.04	0.18	0.11	0.15	0.11	0.06	0.07	0.37
Depreciation	0.22	1.15	1.19	1.28	1.29	1.42	1.47	1.47	1.43	1.47	1.45	1.46
Profit before tax	0.75	3.55	9.52	13.35	14.56	10.13	0.52	0.55	0.53	2.24	1.67	3.06
Tax %	30.67%	0.28%	-0.21%	-0.15%	0.62%	0.39%	25.00%	40.00%	26.42%	32.59%	28.14%	25.16%
	0.53	3.54	9.54	13.36	14.48	10.09	0.39	0.32	0.40	1.52	1.20	2.29
EPS in Rs	0.99	3.39	7.38	9.90	9.22	6.42	0.25	0.20	0.23	0.75	0.51	0.93
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	19%
5 Years:	21%
3 Years:	26%
TTM:	19%

Compounded Profit Growth
10 Years:	-5%
5 Years:	42%
3 Years:	79%
TTM:	91%

Stock Price CAGR
10 Years:	%
5 Years:	-17%
3 Years:	-28%
1 Year:	-42%

Return on Equity
10 Years:	8%
5 Years:	2%
3 Years:	2%
Last Year:	2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2010	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5.33	10.43	12.93	13.50	15.71	15.71	15.71	15.71	17.04	20.38	23.43	24.75
Reserves	11.08	-2.03	9.21	32.68	50.43	60.52	60.91	61.23	64.61	76.66	83.13	85.47
	10.46	13.94	10.94	10.90	1.41	1.30	1.03	1.25	1.55	1.41	1.15	3.96
	3.29	7.00	16.51	13.40	15.30	15.46	14.61	12.44	13.28	8.87	16.22	29.94
Total Liabilities	30.16	29.34	49.59	70.48	82.85	92.99	92.26	90.63	96.48	107.32	123.93	144.12
	18.54	17.12	17.32	17.71	20.85	21.25	19.87	18.53	16.85	15.69	14.38	15.02
CWIP	0.00	0.00	0.00	3.51	0.00	0.00	0.07	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.02	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01
	11.62	12.22	32.25	49.26	62.00	71.74	72.31	72.09	79.62	91.62	109.54	129.09
Total Assets	30.16	29.34	49.59	70.48	82.85	92.99	92.26	90.63	96.48	107.32	123.93	144.12

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2010	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.00	3.04	2.28	12.92	2.62	2.68	0.22	-0.57	-6.59	-12.48	-6.60	-3.59
	0.00	0.00	-1.40	-12.90	-11.53	-1.94	-0.08	-0.05	0.26	-0.30	-0.14	-2.25
	0.00	-2.91	-0.95	0.21	13.07	-1.77	-0.37	0.07	5.06	13.64	8.01	3.97
Net Cash Flow	0.00	0.13	-0.08	0.23	4.16	-1.03	-0.23	-0.55	-1.27	0.86	1.27	-1.87
Free Cash Flow	0.00	3.04	0.88	7.74	1.70	0.87	0.06	-0.63	-6.34	-12.79	-6.74	-5.83
CFO/OP	0%	48%	18%	92%	16%	23%	18%	-6%	-311%	-332%	-207%	-73%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2010	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	50.24	181.82	229.90	170.49	159.86	177.66	134.74	141.07	97.21	60.44	61.26	97.09
Inventory Days	34.08	269.62	432.36	596.97	773.64	825.88	890.81	1,182.75	683.64	445.05	326.33	239.32
Days Payable	31.06	264.36	447.94	173.22	185.88	153.84	112.09	146.00	123.28	41.39	68.52	99.44
Cash Conversion Cycle	53.25	187.08	214.32	594.24	747.62	849.70	913.46	1,177.82	657.58	464.10	319.07	236.98
Working Capital Days	51.72	-155.17	193.82	240.82	321.94	421.77	545.99	603.01	502.26	477.19	423.69	384.77
ROCE %	5.08%		42.08%	32.94%	25.03%	14.21%	0.81%	5.62%	0.79%	2.53%	1.69%	3.09%

Insights

In beta

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Employee Strength (Total)
Number

xxx	xxx	xx	xx	xx	xx	xx	xx
x,xxx	x,xxx	x,xxx	x,xxx	xx	x,xxx	xxx	xxx
x,xxx	x,xxx	x,xxx	xxx	x,xxx	x,xxx	xxx	xxx
x,xxx	xxx	xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
xxx,xxx,xxx	x,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx		xx,xxx,xxx
xxx,xxx,xxx	xx,xxx,xxx	x,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx		xx,xxx,xxx
xx,xxx,xxx	x,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx		xx,xxx,xxx
xxx	x	x	x,xxx	xx	xx		xx
							xxx,xxx

Please log in to see hidden values.

Number of Marketing Agents
Count

Number of SKUs
Count

Recipe Portfolio Count
Count

Monthly Installed Capacity - Hard Gel Food Pills
Units

Monthly Installed Capacity - Soft Gel Food Pills
Units

Monthly Installed Capacity - Tablet Food Pills
Units

Number of Distributors
Count

Unit Distribution (Iron-Enriched Fruit Bars)
Units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	19.27%	19.27%	16.12%	16.12%	16.12%	15.66%	18.26%	19.46%	18.42%	18.42%	18.42%	19.46%
	7.80%	7.80%	6.53%	6.53%	6.53%	6.34%	5.87%	5.68%	5.37%	5.37%	5.37%	5.68%
	72.92%	72.92%	77.35%	77.35%	77.35%	78.02%	75.89%	74.87%	76.20%	76.21%	76.20%	74.87%
No. of Shareholders	1,116	1,645	2,041	2,737	3,002	3,154	3,416	3,614	3,667	3,743	3,926	4,004

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	51.39%	45.61%	35.70%	27.60%	22.21%	16.12%	19.46%	19.46%
	0.00%	0.00%	0.00%	0.00%	7.80%	6.53%	5.68%	5.68%
	48.61%	54.39%	64.30%	72.40%	70.00%	77.35%	74.87%	74.87%
No. of Shareholders	807	694	877	865	897	2,737	3,614	4,004

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Nov 2025

Transcript

AI Summary
PPT
Nov 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
Jun 2024

Transcript

AI Summary
PPT
Jan 2019

Transcript

AI Summary
PPT